MAR 30, 2016 02:34 PM PDT

Bombs Inside of Bombs to Detonate Tumor Basecamps

WRITTEN BY: Xuan Pham
In what sounds like a top-secret military operation, scientists have developed a triple-stage “cluster bomb” to detonate the cancer enemy basecamp. The cluster bombs are smarter and respond to their stimuli in order to penetrate deeper inside the tumor and release cisplatin, a toxic drug with potent anticancer effects.  
 
The triple-stage design was motivated by the need to target cisplatin into the tumor while incurring less collateral damages to the healthy cells. Cisplatin is a platinum-based drug that induces the DNA strands to cross-link, and thereby triggering cell death. Though a potent anticancer weapon, cisplatin has well-documented severe side effects, including kidney damage, nerve damage, and irreversible hearing loss. As such, finding a way to deliver cisplatin to the tumor while sparing healthy cells has been a long-awaited goal for cancer researchers.
 
The new nanoparticle bomb was developed for precisely this purpose by researchers from Emory University and their collaborators. In a clever design, the team created nanoparticles that are about 100 nanometers wide, which the researchers considered to be large enough to travel to the tumor site without getting caught in leaky blood vessels. Once close to the tumor, acidic conditions trigger the release of “bomblets” – smaller bombs about 5 nanometers wide, which can more effectively penetrate the actual tumor. In the third step of the triple-stage design, another chemical activates the cisplatin, detonating the bombs and allowing it to infiltrate the tumor cells.
 

 "The negative side effects of cisplatin are a long-standing limitation for conventional chemotherapy," says Jinzhi Du, postdoctoral fellow at Emory and co-author of the study. "In our study, the delivery system was able to improve tumor penetration to reach more cancer cells, as well as release the drugs specifically inside cancer cells through their size-transition property."
 
In comparing doses of the smart cisplatin bombs to free-floating cisplatin, the researchers found several promising outcomes with the new design. First, they found higher levels of cisplatin with the nanoparticle delivery method in the tumors of a mouse model of human pancreatic cancer. This accumulation of drugs in the targeted tumor site offers hope of reduced damages to the surrounding healthy cells. 

Then, in a cisplatin-resistant lung cancer mouse model, the cisplatin nanoparticles reduced tumor growth by 95 percent, compared to the 10 percent observed for free cisplatin doses. The nanoparticles also were effective against a model of invasive breast cancer, where the new delivery method prolonged animal survival by weeks. That cisplatin nanoparticle bombs were effective in three different tumor models is highly impressive, and offer hope that the system can be applied to many types of cancers.
 

Additional source: Emory University press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 13, 2018
Cancer
JUN 13, 2018
Tailored vaccine boosts survival for some brain cancer patients
In a new multicenter clinical trial, a personalized vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma. Currently...
AUG 07, 2018
Cancer
AUG 07, 2018
Is There a Best Time of Day to Administer Chemo?
A common hematologic cancer chemotherapy agent is looked at for its efficacy on solid tumors and specifically evaluates if delivery time during the day affects is anti-tumor activity....
AUG 10, 2018
Immunology
AUG 10, 2018
Cancer Cell 'Drones' Battle Immune System
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors....
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
SEP 05, 2018
Videos
SEP 05, 2018
Why Glioblastoma Is So Deadly
Senator John McCain passed away recently after battling brain cancer. Most forms of brain cancer are aggressive and difficult to treat because medications...
OCT 05, 2018
Cancer
OCT 05, 2018
FDA approves a new drug for an advanced type of skin cancer
As cancer is one of the most challenging diseases in our world, many efforts have been put into researching new ways for treatment to find new drugs that could help more patients worldwide. A...
Loading Comments...